ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

AACR Supports 5 Percent Increase in NCI Budget.

April 7, 2006

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004

ARRA Funding Announcements Listed

April 10, 2009

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

November issue of Business & Regulatory Report included.

November 28, 2003